Centrum silver and Onglyza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Centrum silver (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Onglyza (saxagliptin hydrochloride). Common drug interactions include pain in jaw among females and blood glucose increased among males.

The phase IV clinical study analyzes what interactions people have when they take Centrum silver and Onglyza. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Centrum silver?

Centrum silver has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 19,997 Centrum silver users. Check the latest studies of Centrum silver.

What is Onglyza?

Onglyza has active ingredients of saxagliptin hydrochloride. It is often used in diabetes. eHealthMe is studying from 8,638 Onglyza users. Check the latest studies of Onglyza.

On Jul, 14, 2026

47 people who take Centrum silver and Onglyza together, and have interactions are studied.

Centrum silver and Onglyza drug interactions.

What are the common drug interactions of Centrum Silver and Onglyza, by gender? *:

female:

Pain in jaw
Platelet count decreased
Precancerous skin lesion
Productive cough
Pruritus (severe itching of the skin)
Pulmonary congestion (congestion in the lungs)
Rectal haemorrhage (bleeding from anus)
Rehabilitation therapy
Renal disorder (kidney disease)
Dehydration (dryness resulting from the removal of water)

male:

Blood glucose increased
Anxiety
Metamorphopsia (a type of distorted vision in which a grid of straight lines appears wavy and parts of the grid may appear blank)
Mood swings (an extreme or rapid change in mood)
Pancreatic pseudocyst (collection of tissue and fluids that forms on pancreas)
Pancreatitis (inflammation of pancreas)
Pancreatitis acute (sudden inflammation of pancreas)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pneumonia
Renal cell carcinoma (a kidney cancer)

What are the common drug interactions of Centrum Silver and Onglyza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Alopecia (absence of hair from areas of the body)
Anxiety
Diarrhoea
Faecal incontinence (a lack of control over passing stool)
Laryngitis (inflammation of the larynx)
Malaise (a feeling of general discomfort or uneasiness)
Mood swings (an extreme or rapid change in mood)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pulmonary congestion (congestion in the lungs)

60+:

Dehydration (dryness resulting from the removal of water)
Hypokalaemia (low potassium)
Diarrhoea
Electrolyte imbalance
Nervousness
Psychiatric symptom
Somnolence (a state of near-sleep, a strong desire for sleep)
Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)
Blood glucose increased
Chest pain

What are the existing conditions these people have? *

Lung Adenocarcinoma (a form of non-small cell lung cancer): 6 people, 12.77%
Hyperkalemia (damage to or disease of the kidney): 5 people, 10.64%
High Blood Pressure: 5 people, 10.64%
High Blood Cholesterol: 5 people, 10.64%
Kidney Stones: 4 people, 8.51%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 8.51%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 8.51%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Centrum silver and Onglyza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously